american heart association glp 1 Assessing the Benefits of GLP-1 RAs - Professional Daily A new study in the

These Products Naturally Brighten Visible Sun Damage, Age Spots, Or Scars

Tirzepatide is a dual-agonist peptide researched for its interaction with both GLP-1 receptors and GIP receptors

In a randomized trial using PET-MRI to assess carotid plaque inflammation, semaglutide did not show a significant difference versus placebo on the prespecified primary plaque-inflammation endpointslikely influenced by low baseline inflammatory burden in a well-treated population. How to interpret this: Imaging studies like this are helpful for understanding mechanisms and terminology (e.g., atherosclerotic inflammation, PET-MRI plaque imaging), but they do not establish semaglutide as a direct vascular inflammation imaging reducer in general clinical use based on current evidence. 5) They Improve Kidney Outcomes in High-Risk Populations (Semaglutide) By improving glycemic control and metabolic stress, GLP-1 therapies can reduce kidney risk in susceptible patients

Aging Cell 16 , 210218 (2017)

Stuessi C, Hofer P, et al

LSD1 demethylates and destabilizes autophagy protein LC3B in ovarian cancer